Starting a cardiac diabetic franchise is actually one of the most promising pharma business opportunities in India today. Are you a new partner? Then just like many others do, you may also ask the same question: How Many Products Should You Start With In A Cardiac Diabetic Franchise? If you pick too few, then here comes a risk of losing prescriptions to competitors who have a much wider basket. And if you pick too many, you’re basically tying up capital in inventory which may not move in your territory at all. Getting the right number here is the difference between a franchise which grows steadily and one that’s just struggling from day one.
At Scott Morrion, we stand out as a leading cardiac diabetic PCD pharma franchise company. Our team works with both first-time pharma entrepreneurs as well as experienced field professionals. The goal here is to help them build a launch range which matches their territory, budget and growth plan. This blog basically breaks down exactly how many products should you start with in a cardiac Diabetic Franchise, without you needing to overextend your resources.
Diabetes and cardiovascular disorders are some of the fastest growing therapeutic areas within the Indian healthcare system. This is precisely why there is an immense demand for the cardiac and diabetic pharma franchise segment currently.
As per a press release issued by the Ministry of Health and Family Welfare according to the ICMR-INDIAB survey (published in the journal, The Lancet Diabetes & Endocrinology), the burden of diabetes in India is around 10.1 crore patients. The national survey also highlighted the prevalence of hypertension among adults in India as being around 35.5%. Source: pib.gov.in – ICMR-INDIAB Study Press Release.
These numbers confirm one thing to be specific: the demand for cardiac and diabetic medicines isn’t really slowing down. But the demand along doesn’t decide your starting product count as well, but your territory size, target doctors, monopoly rights, and monthly budget does.

For most of the new franchisees, the perfect starting range for a cardiac diabetic franchise is between 40 and 60 products. This range is wide enough that it covers the core prescription needs of a general physician, cardiologist or diabetologist. A number like this mostly doesn’t overwhelm your initial stock investment or the working capital.
Here’s why this range works:
Under 30 products may be inadequate for comprehensive therapy – you could have the diabetic medicines but lack the accompanying vitamin, heart medicines or combination drugs that doctors would look for in a single pack.
With 40 to 60 products, you will have the primary cardiac, diabetic medicines, supportive nutraceuticals, and some fast-movers among the combination drugs – sufficient enough to win doctors’ confidence quickly and practice ethical pharma marketing in your territory.
Above 80 to 100 products at launch will suit partners who have an existing distribution network, multiple sub-stockists or even an existing monopoly pharma franchise in operation within a neighbouring territory.
| Franchise Stage | Recommended Products | Approx. Investment Level | Best Suited For |
| Starter Basket | 25 to 35 products | Low to moderate | First-time franchise partners who are testing a new territory |
| Balanced Launch Basket | 40 to 60 products | Moderate | Most new cardiac diabetic PCD franchise partners. This is recommended for best prescription coverage |
| Established/Expansion Basket | 80 to 100+ products | Higher | Partners who have an existing distribution, sub-stockists or even multiple monopoly territories |
Only use this table as a directional guide as your exact investment and margins depend on the specific products and quantities you’re selecting. So remember to always confirm the current pricing with the Scott Morrison team before you finalize your order.
When you’re choosing products for your first order of the cardiac diabetic PCD franchise, take priority to include:
This includes important antidiabetic tablets including metformin and gliclazide-based formulations, plus combined treatments usually used in the treatment of Type 2 diabetes management. See the complete Diabetic Products Range.
This includes essentials for the treatment of hypertension, angina and cholesterol management. This tends to be the most voluminous range in a cardiac diabetic franchise. See the complete Cardio Products Range.
Add combination formulations that target hypertension along with metabolic risk factors, because many patients require treatments for both. Check out our Hypertension & Cardiometabolic Care products.
Supplements that support general health, including nutraceuticals and soft capsules, are often prescribed with cardiac and diabetes medications and have healthy margins too. Explore our Calcium, Vitamins & Antioxidant Care products.
A small selection of injectable formulations completes your pharma basket to complement your doctors who work in hospitals and for emergency prescriptions. Check our Injections category.
The secret to making your cardiac diabetic pharma franchise basket stand out is to start off with a combination of the above five categories – not just sticking to one.
Even experienced field professionals are make these errors while planning a pharma franchise business:
Overstocking slow-moving molecules: Do not stock up on large quatities of any product simply because of its popularity in other regions, as you need to have a basket that is appropriate for your territory’s prescriber base.
Ignoring combination products: With the increasing preference for fixed dose combinations for cardiac and diabetes, there is no point of ignoring them.
Choosing products without checking monopoly rights. Be sure that there is no other partner in your monopoly-based franchise area when selecting your products. This is how you avoid competing with another partner internally.
Underestimating reorder lead time. Running out of a fast moving product because you just started with too thin a range. This an cost you a prescribing doctor permanently.
Skipping product literature and training. A wide range is a good idea only when your field team understands the dosage, indications and positioning for each of the product.
Before you finalize your first order, just work through these questions first:
What is your territory size and prescriber density? It could be a dense urban territory with many cardiologists and diabetologists. This can support a much wider starting basket if you compare than to a smaller semi urban area.
What is your available working capital? Your budget should be able to cover about 2 to 3 reorder cycles comfortably and not just your first stock.
Do you have hospital or nursing-home access? If yes, then include a stronger injectable component from the day one.
Are you a first-time partner or an experienced distributor? First timers should actually lean towards a 40 to 60 product “balanced launch basket” but if you’re an experienced partner, then you can consider more than 80.
What does your monopoly territory agreement cover? Align your product mix with the geography as well as the prescriber based which is defined in your monopoly pharma franchise agreement.
If you’s still not sure about how to apply this framework to your specific city or district, then contact Scott Morrison team for a complete recommendation.
Every territory behaves differently. A franchise located in a metropolitan city will require more emphasis on injectables and hospital supply chain, whereas a semi-urban territory will have to concentrate more on oral tablets and nutraceuticals. This is why partnering with a well-experienced cardiac diabetic pharma franchise company matters:
As a franchise partner with Scott Morrison, you get:
Monopoly-based territory rights, which ensures that you do not compete with any other franchisee over the same doctors
Flexible product selection, i.e., initially offer a limited but focused number of products and increase as per the region’s sales
Products that have received approval from DCGI, have been certified according to WHO-GMP standards and manufactured under an ISO-certified quality system
Fast order fulfillment,, which is done in 24 to 48 hours for most of the locations
Profit margins are attractive, usually between 20 to 30% based on the nature of the products.
All products have a standard shelf life of 18 to 24 months, eliminating the risk of wastage.
PAN India franchise support; you can apply for a cardiac diabetic franchise irrespective of the state/city that you come from.
Ongoing franchise support which includes promotional material, product training and regular range updates
In addition to this, we offer you an elaborate product brochure and categorised catalogues so that you have clarity on pricing, packaging, and margins before deciding on the composition of your first basket. You can also understand how the cardiac diabetic PCD franchise is different from being a distributor from our guide before choosing your business model.
If you’ve set up your Cardiac Diabetic Franchise business successfully, watch these signals when it’s time to expand SKUs:
Instead od stocking 100+ products from the day one, you should be scaling gradually. This is how you keep your inventory lean and your cash flow healthy. All while your cardiac diabetc pharma franchise builds a reputation in the market.
There is no single “right” number that would work for all cardiac diabetic franchise when it comes to one question: How many products should you start with in a Cardiac Diabetic Franchise? However, if we talk about newly formed territories, it would be a safe choice to begin with 40 to 60 products properly selected from the fields of diabetes, cardiovascular disease, hypertension and supportive therapy. In time, as you collect the data from your prescriptions, you can expand your franchise further.
Are you ready to build a product range that fits the needs of your territory? Connect with Scott Morrison now by calling us directly at +91-6280000921 or WhatsApp us for a custom cardiac diabetic franchise price and monopoly territory availability.
Most new partners would require 40 to 60 different products from diabetic, cardio, and hypertension segments so that there is no issue with prescriptions without stocking in excess. A smaller basket of 25 to 35 products will also be sufficient for first-time partners in new territories.
Yes, Scott Morrison provides this flexibility to new partners for their cardiac diabetic PCD franchises. We allow you to start with a focused basket and then expand your product range as regional sales grow.
Some of the core categories include the Diabetic Product Range, Cardio Product Range, Hypertension & Cardiometabolic Care, Calcium & Vitamin support and Injections.
Yes, Scott Morrison now offers you monopoly based territory rights in a way that franchise partners don’t have to compete with each other in the same region.
Yes, all of the products are DCGI approved and also manufactured in WHO-GMP certified, ISO certified facilities which ensures quality and compliance.
Investment actually depends on the product range and territory selected. So contact Scott Morrison directly to get a customised quote on the bases of your staring basket.
Franchise partners can very typically expect a margin in the range of about 20 to 30%. This depends on the products and quantities which are ordered.